Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology & Medical Research
- Sub-Industry: N/A
- Symbol: LON:OXP
- CUSIP: N/A
- Web: www.oxfordpharmascience.com/
- Market Cap: £17.78 million
- Outstanding Shares: 1,205,661,000
- 50 Day Moving Avg: GBX 1.56
- 200 Day Moving Avg: GBX 1.82
- 52 Week Range: GBX 1.41 - GBX 3.61
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.000
- Annual Revenue: $796,000.00
- Price / Sales: 22.34
- Book Value: GBX 0.02 per share
- Price / Book: 0.78
- EBIDTA: ($2,020,000.00)
- Net Margins: -117.14%
- Return on Equity: -4.37%
- Return on Assets: -4.34%
- Average Volume: 352,728 shs.
Frequently Asked Questions for Oxford Pharmascience Group Plc (LON:OXP)
What is Oxford Pharmascience Group Plc's stock symbol?
Oxford Pharmascience Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "OXP."
Who are some of Oxford Pharmascience Group Plc's key competitors?
Some companies that are related to Oxford Pharmascience Group Plc include AEterna Zentaris (AEZS), Scancell Holdings Plc (SCLP), Oncobiologics (ONS), Senomyx (SNMX), Burcon NutraScience Corp (BUR), OncoSec Medical Incorporated (ONCS), Senestech (SNES), Transgenomic (PRPO), Novogen Limited (NVGN), OpGen (OPGN), Metabolix (YTEN), RXi Pharmaceuticals Corporation (RXII), Repros Therapeutics (RPRX), Synairgen plc (SNG), Ampliphi Biosciences Corp (APHB), Ixico Plc (IXI), OncoGenex Pharmaceuticals (ACHV) and Akers Biosciences (AKR).
Who are Oxford Pharmascience Group Plc's key executives?
Oxford Pharmascience Group Plc's management team includes the folowing people:
- Marcelo Leonardo Bravo, Chief Executive Officer, Executive Director
- Christopher Hill, Chief Financial Officer, Executive Director, Company Secretary
- David Robert Norwood, Non-Executive Chairman of the Board
- James Nicholas Gerald White, Non-Executive Deputy Chairman of the Board
- John Geoffery Goddard, Independent Non-Executive Director
- Karl Robertson Van Horn, Independent Non-Executive Director
How do I buy Oxford Pharmascience Group Plc stock?
Shares of Oxford Pharmascience Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Oxford Pharmascience Group Plc's stock price today?
MarketBeat Community Rating for Oxford Pharmascience Group Plc (LON OXP)MarketBeat's community ratings are surveys of what our community members think about Oxford Pharmascience Group Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Oxford Pharmascience Group Plc stock can currently be purchased for approximately GBX 1.48.
Consensus Ratings for Oxford Pharmascience Group Plc (LON:OXP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Oxford Pharmascience Group Plc (LON:OXP)
(Data available from 9/22/2015 forward)
|5/9/2017||N+1 Singer||Reiterated Rating||corporate|
Earnings History for Oxford Pharmascience Group Plc (LON:OXP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Oxford Pharmascience Group Plc (LON:OXP)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Oxford Pharmascience Group Plc (LON:OXP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Oxford Pharmascience Group Plc (LON:OXP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Oxford Pharmascience Group Plc (LON:OXP)
Latest Headlines for Oxford Pharmascience Group Plc (LON:OXP)
Oxford Pharmascience Group Plc (OXP) Chart for Friday, September, 22, 2017